The pharmacological characteristics of phytochemicals have prompted a lot of interest in
their application in disease management. Due to the high incidence of cancer related …

Ongoing research into the application of nanotechnology for cancer treatment and diagnosis
has demonstrated its advantages within contemporary oncology as well as its intrinsic …

The spread of cancer cells to distant organs represents a major clinical challenge in the
treatment of cancer. Epithelial–mesenchymal transition (EMT) has emerged as a key …

The present review discusses recent work on melatonin-mediated circadian regulation, the
metabolic and molecular signaling mechanisms that are involved in human breast cancer …

Cancer stem cells (CSCs) are cells within a tumor that possess the capacity to self-renew
and maintain tumor-initiating capacity through differentiation into the heterogeneous …

Epithelial–mesenchymal transition (EMT) is defined by the loss of epithelial characteristics
and the acquisition of a mesenchymal phenotype. In this process, cells acquire molecular …

We review here the recently emerging relationship between epithelial-mesenchymal
transition (EMT) and breast cancer stem cells (BCSC), and provide analyses of published …

Abstract Dipeptidyl peptidase (DPP)-4 is a multifunctional glycoprotein involved in various
biological and pathologic processes. DPP-4 has been widely recognized as a therapeutic …

Many cancers might be influenced by obesity, including breast cancer, the leading cause of
cancer death among women. Obesity is a complex state associated with multiple …

Carcinomas, cancers of epithelial origin, constitute the majority of all cancers. Loss of
epithelial characteristics is an early step in carcinoma progression. Malignant transformation …